Discover 3,498 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,498
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
for
Phenylketonurias
Location: Orange CA, Dallas TX, Minneapolis MN, Pittsburgh PA,
Sponsor: NGGT INC.
Sex: All
Age: 18 - 55
Code: NCT06332807
Phase 1, Phase 2, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Santa Monica CA, Portland OR, Aurora CO, Calgary,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Duarte CA, San Diego CA, Las Vegas NV, Palo Alto CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Santa Monica CA, La Jolla CA, Las Vegas NV,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase 1, Phase 2, Recruiting
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
for
Hematologic Malignancies,
Location: Duarte CA, Seattle WA, Oklahoma City OK, Houston TX,
Sponsor: Pulmotect, Inc.
Sex: All
Age: 18+
Code: NCT06665100
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
for
EGFRI Induced Acneiform Lesions
Location: Santa Monica CA, Glendale CA, Tacoma WA, Houston TX,
Sponsor: Lutris Pharma Ltd.
Sex: All
Age: 18+
Code: NCT04759664
Phase 2, Recruiting
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
for
Solid Tumors
Location: Santa Monica CA, Duarte CA, West Valley City UT,
Sponsor: Adcentrx Therapeutics
Sex: All
Age: 18+
Code: NCT06710379
Phase 1, Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Santa Monica CA, Beverly Hills CA, Orange CA, Duarte CA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase 1, Recruiting
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
for
Low Back Pain
Location: Beverly Hills CA, Scottsdale AZ, Cleveland TX,
Sponsor: R3 Stem Cell
Sex: All
Age: 20+
Code: NCT06361485
Phase 1, Recruiting
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
for
Locally Advanced / Metastatic Solid Tumors
Location: Los Angeles CA, West Valley City UT, Denver CO,
Sponsor: Crescent Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07335497
Phase 1, Phase 2, Recruiting
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Los Angeles CA, Medford OR, McKinney TX, Waxahachie TX,
Sponsor: Windward Bio
Sex: All
Age: 40 - 70+
Code: NCT07646587
Phase 2, Recruiting
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
for
Healthy Volunteers,
Location: Los Angeles CA, Houston TX, Marrero LA, Miami FL
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05648214
Phase 1, Phase 2, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: West Hollywood CA, Newport Beach CA, Orange CA,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
for
NHL, Multiple Myeloma, Blood Cancer,
Location: Los Angeles CA, Houston TX, Minneapolis MN,
Sponsor: Indapta Therapeutics, INC.
Sex: All
Age: 18+
Code: NCT06119685
Phase 1, Phase 2, Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Location: Burbank CA, Duarte CA, Irvine CA, Santa Maria CA,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT05806515
Phase 2, Recruiting
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
for
Chronic Diabetic Foot Ulcers
Location: Los Angeles CA, Phoenix AZ, Tulsa OK, Opelousas LA,
Sponsor: SerenaGroup, Inc.
Sex: All
Age: 18+
Code: NCT04457752
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Los Angeles CA, Orange CA, San Diego CA, Tucson AZ,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase 3, Recruiting
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
for
Advanced Hepatocellular Carcinoma,
Location: Los Angeles CA, La Jolla CA, Phoenix AZ, San Antonio TX,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06600321
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Los Angeles CA, San Francisco CA, Phoenix AZ,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase 3, Recruiting
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma